The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in revenue , its patent expiration created a deluge of generic competition , significantly eroding its position . While certain firms may seek to capitalize on related treatments , the existing landscape